Literature DB >> 29693234

A retrospective analysis comparing the use of ProCore® with standard fine needle aspiration in endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA).

David J McCracken1, Melanie Bailey2, Marie-Therese McDermott2, Terence E McManus2.   

Abstract

Endobronchial ultrasound has become first line in the investigation of mediastinal lesions suspicious for malignancy in keeping with National Institute for Health and Care Excellence (NICE) guidelines; however, needle size and type required to maximise diagnostic sensitivity remains unclear. Previous meta-analyses have compared the use of ProCore with standard fine needle aspiration in the assessment of pancreatic masses with differences noted only in the number of passes required. We aim to assess whether a ProCore needle improves diagnostic sensitivity in EBUS-TBNA. Complete follow-up data regarding all 235 patients undergoing EBUS-TBNA in a district general hospital has been collected since the service's inception in 2012. Results were collated and retrospectively analysed allowing for calculation of test sensitivity and specificity. Comparison was then made between procedures where standard fine needle aspiration was performed and those using a ProCore needle. Overall sensitivity of EBUS-TBNA was shown to be 85% with a specificity of 100% in keeping with quoted figures from other centres. Standard fine needle aspiration produced a sensitivity of 77% (85/110) versus ProCore sensitivity of 92% (115/125) with a p value of 0.0016. Thirty percent (33/110) of patients undergoing standard fine needle aspiration required an appropriate crossover technique such as mediastinoscopy or CT-guided FNA in order to either obtain or confirm the diagnosis compared with 15% (19/125) of the ProCore group with a p value of 0.0064. Our retrospective analysis shows a statistically significant difference in the diagnostic sensitivity of sampling mediastinal lymphadenopathy using a ProCore needle compared with standard fine needle aspiration. It also shows that a significantly fewer number of patients required further procedures in order to obtain or confirm the diagnosis. This could potentially be confounded by the retrospective nature of the study design; however, due to the statistical significance demonstrated, further study is required.

Entities:  

Keywords:  EBUS; Endobronchial ultrasound; ProCore

Mesh:

Year:  2018        PMID: 29693234     DOI: 10.1007/s11845-018-1816-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  5 in total

1.  Does needle-type increase the diagnostic yield of malignancies in endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)?-a prospective comparative study.

Authors:  Piotr Skrzypczak; Łukasz Gąsiorowski; Magdalena Sielewicz; Magdalena Roszak; Mikołaj Kamiński; Cezary Piwkowski
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

2.  Endosonography Diagnosis with a New ProCore 20G of Mediastinal Metastasis from a Malignant Cutaneous Melanoma.

Authors:  Samuel Galante Romanini; Arthur Ferraz de Almeida; Juliana Silveira Lima de Castro; Juan Pablo Román Serrano; Isabela Trindade Torres; José Celso Ardengh
Journal:  Turk Thorac J       Date:  2021-05

3.  Novel ProCore 25-gauge needle for endobronchial ultrasound-guided transbronchial needle aspiration reduces the puncture time and frequency, with comparable diagnostic rate for mediastinal and hilar lymphadenopathy.

Authors:  Li Yang; Ye Gu; Hai Wang; Dongmei Yu; Haiping Zhang; Hao Wang
Journal:  Thorac Cancer       Date:  2020-01-28       Impact factor: 3.500

Review 4.  Recent advances in convex probe endobronchial ultrasound: a narrative review.

Authors:  Jian Wu; Cen Wu; Chuming Zhou; Wei Zheng; Peng Li
Journal:  Ann Transl Med       Date:  2021-03

Review 5.  Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): Technical Updates and Pathological Yield.

Authors:  Huzaifa A Jaliawala; Samid M Farooqui; Kassem Harris; Tony Abdo; Jean I Keddissi; Houssein A Youness
Journal:  Diagnostics (Basel)       Date:  2021-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.